New rapid test could slash TB diagnosis time in High-Burden regions

NCT ID NCT04752592

Completed Diagnosis Sponsor: Norwegian Institute of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new rapid blood test called SeroSelectTB to see if it can diagnose active tuberculosis (TB) faster than current methods. Over 9,000 adults in South Africa, Tanzania, and Ethiopia who were unwell and suspected of having TB or pneumonia took part. The goal is to provide same-day results at local clinics, reducing delays in starting treatment and potentially lowering the spread of TB.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTIVE TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

active tuberculosis pulmonary tuberculosis tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS, PULMONARY

Contacts and locations

Locations

Kilimanjaro region, Tanzania

Moshi, Tanzania
Sidama region

Awasa, Ethiopia
Stellenbosch University Clinics

Cape Town, Western Cape, 7505, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.